docetaxel anhydrous has been researched along with threonine in 2 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (threonine) | Trials (threonine) | Recent Studies (post-2010) (threonine) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 10,383 | 98 | 2,176 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreu, JM; Barasoain, I; Buey, RM; Calvo, E; Cerezo, G; Day, BW; Díaz, JF; Edler, MC; Hamel, E; López, JA; Matesanz, R; Pineda, O; Sorensen, EJ; Vanderwal, CD | 1 |
| Allory, Y; Carpentier, G; Céraline, J; Courty, J; De La Taille, A; Destouches, D; Maillé, P; Marchand, C; Sader, M; Semprez, F; Soyeux, P; Terry, S; Vacherot, F | 1 |
2 other study(ies) available for docetaxel anhydrous and threonine
| Article | Year |
|---|---|
Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
Topics: Alkanes; Amino Acid Sequence; Asparagine; Binding Sites; Binding, Competitive; Carbamates; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Docetaxel; Epothilones; Humans; Inhibitory Concentration 50; Lactones; Mass Spectrometry; Microtubules; Models, Chemical; Models, Molecular; Molecular Sequence Data; Paclitaxel; Polycyclic Compounds; Protein Binding; Pyrones; Taxoids; Threonine; Tubulin; Tubulin Modulators | 2007 |
Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Humans; Male; Mice, Nude; Nuclear Proteins; Nucleophosmin; Nucleoproteins; Peptides; Phosphorylation; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Binding; Receptors, Androgen; Taxoids; Threonine; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |